Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2010
11/10/2010CN101417131B External medicine combination for treating skin allergic disease
11/10/2010CN101406476B Agent for treating skin peeling and allergy
11/10/2010CN101390985B Traditional Chinese medicine for treating diabetes acral necrosis
11/10/2010CN101284026B Chinese medicinal composition for treating skin hypersensitivity disease
11/10/2010CN101259265B Deep-sea fish collagen oral liquid
11/10/2010CN101204469B Wash-out medicine for folliculitis
11/10/2010CN101199591B Soaking drug for treating limb kibe
11/10/2010CN101185674B Infusion medicine for treating tinea pedis
11/10/2010CN101181427B Externally used medicament for curing scaly tetter
11/10/2010CN101181401B Chinese medicine medicament for curing empyrosis
11/10/2010CN101173270B Method for improving secernment efficiency of recombined protein
11/10/2010CN101147778B Medicine preparation for treating facial stain and breast tumor
11/10/2010CN101125155B Application of erigeron breviscapus methanol extracts in skin-whitening and speckle eliminating prevention
11/10/2010CN101053597B Medicine for treating skin disease and beauty and preparation method thereof
11/10/2010CN101028365B Medicine for treating burn and ambustion and its production
11/10/2010CN101002796B Application of nanometer montmorillonite for pharmaceutical use, and medicine compositions therewith
11/09/2010US7829675 TWEAK receptor
11/09/2010US7829573 Therapeutic combinations of antihypertensive and antiangiogenics agents
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010US7829518 Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
11/09/2010US7829110 increasing tear resistance of scar tissue during wound repair by applying to a wound a surgical mesh comprising an anabolic steroid and a corticosteroid disposed in or on a surgical mesh structure
11/09/2010US7829095 Produced by hybridoma cell line DSM ACC 2533
11/09/2010US7829090 Human antibody molecules for IL-13
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2407659C Growth hormone secretagogues
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/09/2010CA2326654C Use of steroidal alkaloid derivatives as inhibitors of hedgehog signaling pathways
11/09/2010CA2223532C Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
11/04/2010WO2010126982A1 Oral compositions for skin benefits
11/04/2010WO2010126260A2 Pharmaceutical composition for promoting the healing of wounds and containing lysophosphatidic acid and an adenylyl cyclase inhibitor as active ingredients
11/04/2010WO2010126167A1 Thiophene derivative
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010126102A1 Scca-1 production inhibitor having a carboxamide derivative and/or a salt thereof as an active ingredient
11/04/2010WO2010126034A1 Novel compound, histone acetylase inhibitor, nuclear receptor transcription activation inhibitor, deuteromycetes belonging to genus penicillium, and production process
11/04/2010WO2010126022A1 Imidazole derivative
11/04/2010WO2010125910A1 Collagen peptide composition having good blood transfer properties, and food and drink containing same
11/04/2010WO2010125811A1 Carbinol compound having heterocyclic linker
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125445A1 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
11/04/2010WO2010125340A1 Use of pufas for treating skin inflammation
11/04/2010WO2010125143A1 Use of allopurinol for the treatment of hand foot skin reaction
11/04/2010WO2010124540A1 Flexible liposome of resveratrol and preparation method thereof
11/04/2010WO2010124521A1 Derivatives of rhein, preparation methods and uses thereof
11/04/2010WO2010077971A3 Acne treatment powder foundation
11/04/2010WO2010071769A3 Chimeric l. monocytogens in1b protein
11/04/2010WO2009141142A8 Nanoparticles functionalized with sulfated amino alcohols for the inhibition of selectin-mediated cell adhesion
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280121 Production of adapalene gels
11/04/2010US20100280107 Treating benign prostate hyperplasia with sarms
11/04/2010US20100280087 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
11/04/2010US20100280086 Substituted thiophenes
11/04/2010US20100280079 0novel, 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280073 Tricyclic inhibitors of hydroxysteroid dehydrogenases
11/04/2010US20100280051 Use of allopurinol for the treatment of hand foot skin reaction
11/04/2010US20100280049 Antagonists of pgd2 receptors
11/04/2010US20100280048 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
11/04/2010US20100280046 Methods and Compositions for Treating Prostate Cancer, Benign Prostatic Hypertrophy, Polycystic Ovary Syndrome and Other Conditions
11/04/2010US20100280015 Noval 1,4-diaza-biclo[3.2.2]nonyl oxadiazolyl derivatives useful as nicotinic acetylcholine receptor ligands
11/04/2010US20100280013 Carbinol derivatives having heterocyclic linker
11/04/2010US20100280001 Imidazoquinolines with immuno-modulating properties
11/04/2010US20100279992 Use of lanostane and poria extract in treating cachexia
11/04/2010US20100279990 Antiproliferative compounds, compositions and methods of use
11/04/2010US20100279987 Compositions containing chalcones and use thereof
11/04/2010US20100279975 Compounds and methods associated with differential methylation of human papilloma virus genomes in epithelial cells
11/04/2010US20100279961 Pharmaceutical composition having a trihydroxy-chromenone derivative
11/04/2010US20100279959 Medium-Chain Length Fatty Acids, Glycerides and Analogues as Neutrophil Survival and Activation Factors
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279946 Use of an active principle from flax for use in a composition for activating cytochrome c
11/04/2010US20100279934 Topical compositions for delivery of proteins and peptides
11/04/2010US20100279932 Binding constructs and methods for use thereof
11/04/2010US20100279927 Growth factor complex
11/04/2010US20100279922 Melanocortin Receptor Ligands
11/04/2010US20100279921 Impaired wound healing compositions and treatments
11/04/2010US20100279919 Compositions comprising human integrin-linked kinase-sirna and methods of use thereof
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100278916 Topical application and formulation of erythropoietin for skin wound healing
11/04/2010US20100278914 Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same
11/04/2010US20100278906 Moisturizing antimicrobial composition
11/04/2010US20100278896 Solid compositions
11/04/2010US20100278887 Use of a Haemoglobin for the Preparation of Dressings and Resulting Dressings
11/04/2010US20100278877 Body tissue filling material and method for production thereof
11/04/2010US20100278838 Epha2 monoclonal antibodies and methods of use thereof
11/04/2010US20100278829 Dual inhibition of immunophilin/cyclophilin family members and emmprin immunoglobulin receptor superfamily members
11/04/2010US20100278798 Methods and systems for forming biocompatible materials
11/04/2010US20100278793 Treatment of greasy skin with a bacterial lystate
11/04/2010US20100278784 Methods and compositions for treating skin conditions
11/04/2010US20100278781 Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
11/04/2010US20100278765 Regulation of mammalian keratinous tissue using hexamidine compositions
11/04/2010US20100278760 Cosmetics
11/04/2010US20100278759 Topical Therapeutic Delivery System
11/04/2010US20100278757 Water-Absorbent Adhesive Compositions and Associated Methods of Manufacture and Use
11/04/2010US20100278756 Peptides having activities of insulin like growth factor-1 and their uses
11/04/2010DE102009020314A1 Mittel zur Bekämpfung von Nebenwirkungen der Krebs-Chemotherapie Agent for controlling side effects of cancer chemotherapy
11/04/2010DE102009019104A1 Kosmetische oder dermatologische Zusammensetzung enthaltend Hydrolysate aus Pflanzenextrakten Cosmetic or dermatological composition containing hydrolysates of plant extracts
11/04/2010DE102009017966A1 Healthy liquid food/food supplement, useful e.g. in a dried plant extract, which is useful to prepare an infusion drink, comprises a sliced nettle leaf, sliced horsetail, speedwell herb and honey, in an aqueous solution
11/04/2010CA2843996A1 Use of pufas for treating skin inflammation
11/04/2010CA2760629A1 Use of pufas for treating skin inflammation
11/04/2010CA2760387A1 Thiophene derivative
1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 1065